• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Oncology

Patient-reported feedback may not improve health-related quality of life

byMonica ParksandAndrew Bishara
March 14, 2014
in Oncology, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

 1. Patient-reported feedback through the computer-based PediQUEST survey to oncologists and families does not significantly affect symptoms or health related quality of life (HRQoL).

2. Initial analysis suggests positive, though not statistically significant, effects on emotional quality of life, and reports are valued by families.

Evidence rating level: 2 (Good)

Study Rundown: Multiple approaches have been taken towards improving the quality of life for pediatric patients with advanced cancer. One approach involves providing patient-reported outcomes (PROs) to providers and families. The purpose of this study was to determine whether providing this data to providers and families of these patients affects symptom severity and health-related quality of life (HRQoL). At the conclusion of this multicenter trial, the authors found that this feedback did not significantly affect symptom severity, HRQoL, or sickness score trends. Subgroup analysis suggested that emotional quality of life and sickness scores improved significantly among children >8 years old who survived twenty weeks. Furthermore, the survey reports were highly valued by the patients, families and providers. Based off these results, the authors concluded that this intervention still has clinical potential. It should be noted that effect size of the intervention may have been reduced by PROs measured in the control arm, possible bias skewed towards the null due to patient mortality, and low intensity of the intervention.

Click to read the article in JCO

Relevant reading: Easing of suffering in children with cancer at the end of life: Is care changing?

RELATED REPORTS

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

Early-life body size not an independent risk factor for colorectal cancer

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

In-Depth [randomized controlled trial]: This study was a randomized controlled trial enrolling children 2 years old or older with advanced cancer. Patients or their parents completed the computer-based Pediatric Quality of Life and Evaluation of Symptoms Technology (PediQUEST) survey, which consisted of age-adapted versions of questions from the Memorial Symptom Assessment Scale (MSAS), Pediatric Quality of life scales (PedsQL4.0) and overall Sickness. The intervention group included 51 patients, and oncologists and families received summary results of PROs. The control group, which included 53 patients, had no feedback. Primary outcomes included the scores on MSAS, PedsQL4.0 and Sickness socres during 20 weeks of follow-up along with satisfaction reports from patients, families and providers. No significant relationship between feedback and average scores was found overall. However, among children aged >8 years who survived the 20 weeks, feedback improved PedsQL4.0 emotional (+8.1; 95% CI, 1.8 TO 14.4) and Sickness (-8.2; 95% CI, -14.2 to -2.2) scores. Satisfaction scores from children, parents and providers suggested a preference for continued use.

More from this author: Rituximab linked with reduced chronic immune disease following stem cell transplantation, High-dose prophylaxis for hemophilia increases costs with minimal benefit, Ambrisentan found ineffective against idiopathic pulmonary fibrosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: computer-basedfeedbackoncologyoutcomespatient-reported feedbackquality of life
Previous Post

Rotavirus vaccine 116E shown effective and affordable in India

Next Post

Stereotactic radiosurgery promising for patients with multiple brain metastases

RelatedReports

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer
StudyGraphics

#VisualAbstract: Tamoxifen increases the risk of endometrial cancer in premenopausal women with breast cancer

January 24, 2023
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs
Chronic Disease

Early-life body size not an independent risk factor for colorectal cancer

January 11, 2023
No benefit of erlotinib in combined hepatocellular carcinoma treatment
Oncology

Spiritual care reduces fatigue and pain among patients receiving chemotherapy

January 11, 2023
Similar outcomes after supracervical vs. total hysterectomy
Oncology

Characterization of prognostic markers of residual neoplastic disease following hysterectomy

January 4, 2023
Next Post
Stereotactic radiosurgery promising for patients with multiple brain metastases

Stereotactic radiosurgery promising for patients with multiple brain metastases

Home scoring system may prevent unnecessary pharyngitis clinic visits

New sepsis scoring system aids in predicting morbidity in obstetric patients

Increased infections noted with longer duration neonatal PICC placement

Biofilm-producing staphylococci occlude eccrine sweat ducts in atopic dermatitis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cystatin C-based equation without race or sex improves accuracy of GFR estimation
  • #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with treatment-resistant hypertension
  • High-dose exercise therapy is not superior to low-dose exercise therapy for knee osteoarthritis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options